Skip to content

Clinical trials

Carcinoma, Non-Small-Cell Lung trials in Australia with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Unknown status Country / region: Australia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20161
20172
20204
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Western Sydney Local Health District2
Effector Therapeutics1
GeneQuantum Healthcare (Suzhou) Co., Ltd.1
ImaginAb, Inc.1
Olivia Newton-John Cancer Research Institute1
Royal Marsden NHS Foundation Trust1
Shanghai Henlius Biotech1
Silverback Therapeutics1
The University of Queensland1
Trans Tasman Radiation Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung11
Biliary Tract Neoplasms2
Breast Neoplasms2
Carcinoma, Renal Cell2
Endometrial Neoplasms2
Lung Neoplasms2
Melanoma2
Stomach Neoplasms2
Carcinoma, Hepatocellular1
Carcinoma, Merkel Cell1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.